AZN•Rhythm Pharmaceuticals shares closed 28% higher at $110.68 after AstraZeneca reportedly made a roughly $10 billion takeover offer last month at $124 per share.
Rhythm Pharmaceuticals shares closed up 28% at $110.68 after a report said AstraZeneca made a roughly $10 billion takeover offer for the company last month, offering $124 per share. The report cited people familiar with the matter. AstraZeneca declined to comment, while Rhythm did not respond to a request for comment. Rhythm shares traded at $108.44 in extended trading.
